Index NDX, S&P 500
P/E 56.66
EPS (ttm) 8.31
Insider Own 0.30%
Shs Outstand 82.99M
Perf Week 2.79%
Market Cap 39.00B
Forward P/E 42.51
EPS next Y 11.08
Insider Trans -13.56%
Shs Float 82.01M
Perf Month -1.67%
Income 699.20M
PEG 3.63
EPS next Q 2.47
Inst Own 91.80%
Short Float / Ratio 2.70% / 5.70
Perf Quarter -3.52%
Sales 3.43B
P/S 11.37
EPS this Y -6.70%
Inst Trans -0.23%
Short Interest 2.21M
Perf Half Y 10.56%
Book/sh 10.13
P/B 46.48
EPS next Y 14.26%
ROA 25.90%
Target Price 559.67
Perf Year 27.38%
Cash/sh 1.34
P/C 350.08
EPS next 5Y 15.60%
ROE 117.40%
52W Range 317.06 - 515.79
Perf YTD 15.41%
Dividend -
P/FCF 85.58
EPS past 5Y 19.60%
ROI 36.70%
52W High -8.72%
Beta 1.19
Dividend % -
Quick Ratio 0.70
Sales past 5Y 11.30%
Gross Margin 59.70%
52W Low 48.50%
ATR 12.27
Employees 10780
Current Ratio 1.10
Sales Q/Q 7.60%
Oper. Margin 27.10%
RSI (14) 46.04
Volatility 2.45% 2.41%
Optionable Yes
Debt/Eq 1.43
EPS Q/Q 12.50%
Profit Margin 20.40%
Rel Volume 0.99
Prev Close 469.84
Shortable Yes
LT Debt/Eq 0.83
Earnings May 02 BMO
Payout 0.00%
Avg Volume 387.97K
Price 470.83
Recom 2.20
SMA20 -1.60%
SMA50 -2.31%
SMA200 9.63%
Volume 384,155
Change 0.21%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-25-22 Downgrade
Stifel
Buy → Hold
$415
Jul-21-22 Upgrade
Goldman
Neutral → Buy
$530 → $435
Jul-12-22 Initiated
Piper Sandler
Overweight
$440
May-05-22 Downgrade
BofA Securities
Buy → Neutral
$550 → $470
Feb-08-22 Initiated
Atlantic Equities
Overweight
$650
Nov-18-21 Initiated
Morgan Stanley
Overweight
Aug-05-21 Resumed
Credit Suisse
Outperform
$735
Jul-12-21 Downgrade
Guggenheim
Buy → Neutral
Feb-17-21 Initiated
Barclays
Overweight
$600
Sep-09-19 Initiated
Goldman
Neutral
$277
May-23-19 Initiated
Guggenheim
Buy
$276
Nov-02-18 Reiterated
BofA/Merrill
Buy
$275 → $235
May-07-18 Reiterated
Stifel
Buy
$215 → $225
Jan-16-18 Initiated
Piper Jaffray
Overweight
$200
Aug-23-17 Upgrade
BofA/Merrill
Neutral → Buy
Jul-28-17 Upgrade
CL King
Neutral → Buy
Feb-03-17 Downgrade
Feltl & Co.
Hold → Sell
Sep-29-16 Resumed
BofA/Merrill
Neutral
Aug-16-16 Reiterated
Stifel
Buy
$120 → $125
Aug-03-16 Upgrade
Northcoast
Sell → Neutral
Show Previous Ratings
Jun-01-23 11:31AM
May-29-23 06:14AM
May-23-23 07:50PM (Morningstar Research) -5.18%
May-22-23 08:00AM
May-17-23 09:00AM
09:15AM
Loading…
May-10-23 09:15AM
07:45AM
May-06-23 09:00AM
May-03-23 06:25AM
May-02-23 11:09PM (Thomson Reuters StreetEvents)
12:02PM
10:30AM
07:45AM
06:30AM
02:28AM
10:07AM
Loading…
Apr-28-23 10:07AM
Apr-27-23 12:49PM
10:02AM
Apr-26-23 08:00PM
Apr-25-23 10:56AM
10:01AM
Apr-24-23 02:35PM
Apr-22-23 07:00AM
Apr-21-23 11:28AM
08:21AM
Apr-20-23 10:41AM
10:37AM
Apr-18-23 11:32AM
Apr-14-23 09:00AM
Apr-13-23 03:00PM
11:40AM
Loading…
Apr-12-23 11:40AM
Apr-10-23 11:00AM
Apr-06-23 07:00AM
Mar-31-23 07:35AM
Mar-18-23 08:00AM
Mar-14-23 10:01AM
Mar-08-23 11:40AM
11:30AM
Mar-06-23 07:00AM
Feb-28-23 11:12AM
Feb-27-23 09:38AM
09:00AM
04:42AM (Zacks Small Cap Research)
Feb-24-23 03:13AM
Feb-23-23 10:27AM
09:40AM
Feb-21-23 04:05PM
Feb-20-23 11:40AM
07:00AM
Feb-16-23 06:01AM
Feb-13-23 11:05PM
09:37AM
05:34AM
Feb-12-23 07:00AM
Feb-10-23 09:45AM
Feb-08-23 09:00AM
06:00AM
Feb-07-23 02:38PM
09:40AM
Feb-06-23 04:33PM
10:57AM
10:54AM
07:45AM
06:30AM
Feb-04-23 06:00AM
Feb-03-23 08:30AM
Feb-02-23 10:00AM
Feb-01-23 05:00AM
Jan-31-23 11:40AM
06:47AM
Jan-26-23 08:15AM
Jan-25-23 10:35AM
10:00AM
Jan-23-23 09:30AM
Jan-18-23 08:30AM
Jan-17-23 12:10PM
09:40AM
Jan-13-23 11:10AM
Jan-12-23 07:01AM
Jan-10-23 07:15PM
Jan-09-23 02:37PM (Investor's Business Daily)
Jan-08-23 06:00AM
Jan-04-23 06:01AM
Dec-26-22 06:10AM
Dec-22-22 02:35PM
Dec-15-22 09:25AM
Dec-14-22 10:28AM
Dec-12-22 05:55AM
Dec-07-22 11:41AM
Dec-02-22 11:31AM
Nov-08-22 05:55AM
Nov-01-22 06:29PM
12:15PM
10:44AM
07:45AM
06:30AM
Oct-31-22 11:35AM
Oct-26-22 10:01AM
Oct-25-22 10:01AM
Oct-19-22 12:35PM
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
AYERS JONATHAN W Director May 19 Option Exercise 79.54 10,000 795,400 147,039 May 22 05:00 PM AYERS JONATHAN W Director May 19 Sale 491.35 10,000 4,913,502 137,039 May 22 05:00 PM AYERS JONATHAN W Director May 18 Option Exercise 79.54 10,000 795,400 147,039 May 22 05:00 PM AYERS JONATHAN W Director May 18 Sale 489.23 10,000 4,892,268 137,039 May 22 05:00 PM SZOSTAK M ANNE Director May 11 Option Exercise 0.00 344 0 1,604 May 15 05:32 PM Vandebroek Sophie V. Director May 11 Option Exercise 0.00 344 0 1,216 May 15 05:32 PM COLLINS Asha Director May 11 Option Exercise 0.00 344 0 522 May 15 05:31 PM ESSIG STUART Director May 11 Option Exercise 0.00 344 0 1,717 May 15 05:31 PM Kingsley Lawrence D Director May 11 Option Exercise 0.00 464 0 8,544 May 15 05:32 PM AYERS JONATHAN W Director May 11 Option Exercise 0.00 344 0 140,553 May 15 05:31 PM AYERS JONATHAN W Director May 10 Option Exercise 178.26 560 99,826 141,894 May 11 05:01 PM Underberg Sharon E. EVP, GC & Corporate Secretary May 05 Option Exercise 206.94 483 99,952 4,245 May 08 05:04 PM MCKEON BRIAN P EVP, CFO and Treasurer May 05 Option Exercise 178.26 560 99,826 29,605 May 08 05:02 PM SZOSTAK M ANNE Director May 05 Sale 474.89 2,000 949,789 4,700 May 08 05:03 PM Lane Michael Executive Vice President May 05 Sale 484.00 1,000 484,000 4,022 May 08 05:01 PM Vandebroek Sophie V. Director May 04 Option Exercise 206.62 2,187 451,878 3,059 May 05 06:01 PM MAZELSKY JONATHAN JAY President and CEO May 04 Option Exercise 178.26 560 99,826 73,301 May 05 06:00 PM Vandebroek Sophie V. Director May 04 Sale 469.02 2,187 1,025,740 872 May 05 06:01 PM JUNIUS DANIEL M Director Feb 16 Option Exercise 206.62 2,187 451,878 5,169 Feb 17 05:06 PM Turner Kathy V Senior Vice President Feb 16 Option Exercise 79.54 10 795 7,390 Feb 17 05:04 PM JUNIUS DANIEL M Director Feb 16 Sale 511.68 2,187 1,119,044 2,982 Feb 17 05:06 PM Turner Kathy V Senior Vice President Feb 16 Sale 515.58 10 5,156 7,380 Feb 17 05:04 PM Turner Kathy V Senior Vice President Feb 15 Sale 510.03 1,000 510,031 7,380 Feb 17 05:04 PM Turner Kathy V Senior Vice President Feb 14 Option Exercise 58.23 2,732 159,080 9,380 Feb 16 06:56 PM POLEWACZYK JAMES F Executive Vice President Feb 14 Option Exercise 0.00 834 0 16,605 Feb 16 06:54 PM Smith Martin Alexander Executive Vice President Feb 14 Option Exercise 0.00 149 0 227 Feb 16 06:55 PM MCKEON BRIAN P Executive VP & CFO Feb 14 Option Exercise 0.00 1,928 0 30,239 Feb 16 06:53 PM MAZELSKY JONATHAN JAY President & CEO Feb 14 Option Exercise 0.00 3,561 0 74,384 Feb 16 06:52 PM Hunt Nimrata Executive Vice President Feb 14 Option Exercise 0.00 791 0 11,254 Feb 16 06:51 PM Lane Michael Executive Vice President Feb 14 Option Exercise 0.00 915 0 5,282 Feb 16 06:51 PM Underberg Sharon E. EVP, GC & Corp. Secretary Feb 14 Option Exercise 0.00 1,010 0 4,052 Feb 16 06:56 PM Turner Kathy V Senior Vice President Feb 14 Sale 504.59 2,000 1,009,189 7,380 Feb 16 06:56 PM Hunt Nimrata Executive Vice President Feb 09 Option Exercise 141.60 706 99,970 10,463 Feb 10 05:00 PM Turner Kathy V Senior Vice President Feb 09 Option Exercise 79.54 1,000 79,540 7,941 Feb 13 05:01 PM Turner Kathy V Senior Vice President Feb 09 Sale 505.04 1,000 505,037 6,941 Feb 13 05:01 PM JUNIUS DANIEL M Director Dec 05 Option Exercise 160.28 3,046 488,213 6,014 Dec 07 04:30 PM JUNIUS DANIEL M Director Dec 05 Sale 424.91 3,046 1,294,276 2,968 Dec 07 04:30 PM SZOSTAK M ANNE Director Dec 02 Option Exercise 160.28 2,000 320,560 2,000 Dec 06 05:01 PM SZOSTAK M ANNE Director Dec 02 Sale 428.55 740 317,127 1,260 Dec 06 05:01 PM Turner Kathy V Senior Vice President Dec 01 Option Exercise 141.60 3,000 424,800 9,923 Dec 05 05:00 PM Turner Kathy V Senior Vice President Dec 01 Sale 436.00 3,000 1,308,000 6,923 Dec 05 05:00 PM MAZELSKY JONATHAN JAY President & CEO Nov 14 Option Exercise 62.00 18,998 1,177,876 81,305 Nov 16 05:00 PM MAZELSKY JONATHAN JAY President & CEO Nov 14 Sale 434.47 10,500 4,561,912 70,805 Nov 16 05:00 PM Turner Kathy V Senior Vice President Nov 11 Option Exercise 178.26 8,567 1,527,153 15,490 Nov 14 05:00 PM Turner Kathy V Senior Vice President Nov 11 Sale 438.53 8,567 3,756,921 6,923 Nov 14 05:00 PM Turner Kathy V Senior Vice President Nov 10 Option Exercise 206.94 5,310 1,098,851 12,233 Nov 14 05:00 PM Turner Kathy V Senior Vice President Nov 10 Sale 407.62 5,310 2,164,460 6,923 Nov 14 05:00 PM MAZELSKY JONATHAN JAY President & CEO Nov 07 Option Exercise 52.00 24,002 1,248,104 75,537 Nov 09 05:00 PM MAZELSKY JONATHAN JAY President & CEO Nov 07 Sale 382.49 13,230 5,060,319 62,307 Nov 09 05:00 PM Smith Martin Alexander Executive Vice President Sep 01 Option Exercise 0.00 19 0 49 Sep 06 05:00 PM MAZELSKY JONATHAN JAY President & CEO Aug 05 Option Exercise 0.00 385 0 51,697 Aug 08 05:00 PM MCKEON BRIAN P Executive VP & CFO Aug 05 Option Exercise 0.00 192 0 28,366 Aug 08 05:01 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite